Hereditary spherocytosis screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 6: Line 6:


==Overview==
==Overview==
* There is no screening test for HS has been recommended.
The combination of two [[Test|tests]]; [[Mean corpuscular hemoglobin concentration|mean corpuscular hemoglobin concentration (MCHC)]] and [[Red blood cell distribution width|erythrocyte distribution width]] are an excellent [[Screening (medicine)|screening tests]] for [[hereditary spherocytosis]]. For [[Young adult|young]] [[Patient|patients]] with the [[disease]], a full [[family history]], [[Complete blood count|complete blood count (CBC)]], [[Reticulocyte|reticulocyte count]] and [[Physical examination|examination]] of [[Blood film|peripheral blood smear]] on each parent and sibling is required to determine whether the [[Spherocytosis|spherocytic]] [[mutation]] is [[Autosomal dominant|dominant]] or [[Autosomal recessive|recessive]]. For individuals of childbearing [[Ageing|age]] with [[hereditary spherocytosis]], review of [[Family|familial]] [[mutation]] and its mode of [[Transmission (medicine)|transmission]] is useful for discussions of likelihood of [[disease]] in [[Child|children]].
* For individuals of childbearing age with HS, review of the familial mutation and its mode of transmission (autosomal dominant or recessive) may be useful for informing discussions of the likelihood of HS in children. If the familial mutation is known to act in an autosomal dominant fashion, it is important to make this information clear in the prenatal record and to make the information available to the pediatrician before delivery.


==Screening==
==Screening==
* The screening test used for hereditary spherocytosis is automated mean cell hemoglobin concentration (MCHC).<ref>{{Cite journal
* The [[Screening (medicine)|screening test]] used for [[hereditary spherocytosis]] is automated [[Mean corpuscular hemoglobin concentration|mean cell hemoglobin concentration (MCHC)]].<ref>{{Cite journal
  | author = [[L. A. Michaels]], [[A. R. Cohen]], [[H. Zhao]], [[R. I. Raphael]] & [[C. S. Manno]]
  | author = [[L. A. Michaels]], [[A. R. Cohen]], [[H. Zhao]], [[R. I. Raphael]] & [[C. S. Manno]]
  | title = Screening for hereditary spherocytosis by use of automated erythrocyte indexes
  | title = Screening for hereditary spherocytosis by use of automated erythrocyte indexes
Line 21: Line 20:
  | pmid = 9202619
  | pmid = 9202619
}}</ref>
}}</ref>
* Erythrocyte distribution width when raised is also useful as a powerful screening test.<ref>{{Cite journal
* [[Red blood cell distribution width|Erythrocyte distribution width]] when raised is also useful as a powerful [[Screening (medicine)|screening test]].<ref>{{Cite journal
  | author = [[Silvia Eandi Eberle]], [[Gabriela Sciuccati]], [[Mariana Bonduel]], [[Lilian Diaz]], [[Raquel Staciuk]] & [[Aurora Feliu Torres]]
  | author = [[Silvia Eandi Eberle]], [[Gabriela Sciuccati]], [[Mariana Bonduel]], [[Lilian Diaz]], [[Raquel Staciuk]] & [[Aurora Feliu Torres]]
  | title = &#91;Erythrocyte indexes in hereditary spherocytosis&#93;
  | title = &#91;Erythrocyte indexes in hereditary spherocytosis&#93;
Line 32: Line 31:
  | pmid = 18422060
  | pmid = 18422060
}}</ref>
}}</ref>
* The combination of these two tests (MCHC & erythrocyte distribution width) is an excellent predictor for the diagnosis of hereditary spherocytosis.<ref name="MichaelsCohen1997">{{cite journal|last1=Michaels|first1=Lisa A.|last2=Cohen|first2=Alan R.|last3=Zhao|first3=Huaqing|last4=Raphael|first4=Robert I.|last5=Manno|first5=Catherine S.|title=Screening for hereditary spherocytosis by use of automated erythrocyte indexes|journal=The Journal of Pediatrics|volume=130|issue=6|year=1997|pages=957–960|issn=00223476|doi=10.1016/S0022-3476(97)70283-X}}</ref>
* The combination of these two [[Test|tests]] ([[Mean corpuscular hemoglobin concentration|MCHC]] & [[Red blood cell distribution width|erythrocyte distribution width]]) is an excellent predictor for the [[diagnosis]] of [[hereditary spherocytosis]].<ref name="MichaelsCohen1997">{{cite journal|last1=Michaels|first1=Lisa A.|last2=Cohen|first2=Alan R.|last3=Zhao|first3=Huaqing|last4=Raphael|first4=Robert I.|last5=Manno|first5=Catherine S.|title=Screening for hereditary spherocytosis by use of automated erythrocyte indexes|journal=The Journal of Pediatrics|volume=130|issue=6|year=1997|pages=957–960|issn=00223476|doi=10.1016/S0022-3476(97)70283-X}}</ref>
* For [[Young adult|young]] [[Patient|patients]] with [[hereditary spherocytosis]], a full [[family history]] and [[Complete blood count|CBC]], [[Reticulocyte|reticulocyte count]], and [[Physical examination|examination]] of the [[Blood film|peripheral blood smear]] on each parent and sibling is required to determine whether the [[Spherocytosis|spherocytic]] [[mutation]] is [[Autosomal dominant|dominant]] or [[Autosomal recessive|recessive]].
* Appropriate [[counseling]] is also required once this information has been obtained and it is especially important to [[test]] a [[Infant|newborn]] sibling for [[hereditary spherocytosis]], as this may be associated with severe degrees of [[Jaundice|hyperbilirubinemia]] and [[anemia]] during this period.


 
* For individuals of childbearing age with [[hereditary spherocytosis]], review of the [[Family|familial]] [[mutation]] and its mode of [[Transmission (medicine)|transmission]] ([[autosomal dominant]] or [[Autosomal recessive|recessive]]) may be useful for informing discussions of the likelihood of [[hereditary spherocytosis]] in [[Child|children]]. If the [[Family|familial]] [[mutation]] is known to act in an [[autosomal dominant]] fashion, it is important to make this information clear in the prenatal record and to make the information available to the [[Pediatrics|pediatrician]] before [[Childbirth|delivery]].<ref name="pmid26009624">{{cite journal| author=Christensen RD, Yaish HM, Gallagher PG| title=A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates. | journal=Pediatrics | year= 2015 | volume= 135 | issue= 6 | pages= 1107-14 | pmid=26009624 | doi=10.1542/peds.2014-3516 | pmc=4444801 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26009624  }}</ref>
 
* It is also important to [[test]] [[Infant|newborns]] of affected parents for [[hereditary spherocytosis]], as affected [[Infant|newborns]] may have severe [[Jaundice|hyperbilirubinemia]] and [[anemia]].
'''Prenatal testing, family testing, and genetic counseling''' —
* For young patients with HS, we obtain a full family history and obtain a CBC, reticulocyte count, and examination of the peripheral blood smear on each parent and sibling in order to determine whether the spherocytic mutation is dominant or recessive. Appropriate counseling can be performed once this information has been obtained. It is especially important to test a newborn sibling for HS, as this may be associated with severe degrees of hyperbilirubinemia and anemia during this period.
 
* For individuals of childbearing age with HS, review of the familial mutation and its mode of transmission (autosomal dominant or recessive) may be useful for informing discussions of the likelihood of HS in children. If the familial mutation is known to act in an autosomal dominant fashion, it is important to make this information clear in the prenatal record and to make the information available to the pediatrician before delivery.<ref name="pmid26009624">{{cite journal| author=Christensen RD, Yaish HM, Gallagher PG| title=A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates. | journal=Pediatrics | year= 2015 | volume= 135 | issue= 6 | pages= 1107-14 | pmid=26009624 | doi=10.1542/peds.2014-3516 | pmc=4444801 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26009624  }}</ref> Some individuals who had HS as a child and were treated with splenectomy may have forgotten about the condition or may not realize the implications for their child.
 
* It is also important to test newborns of affected parents for HS, as affected newborns may have severe hyperbilirubinemia and anemia. This may be done by a clinician with expertise in hemolytic anemias or by a genetic counselor. It is possible for an individual with no hemolysis, no spherocytes on the blood smear, and a normal reticulocyte count to be a carrier of HS, which may be relevant in certain families


==References==
==References==

Latest revision as of 17:35, 6 December 2018

Hereditary spherocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary spherocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hereditary spherocytosis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary spherocytosis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary spherocytosis screening

CDC on Hereditary spherocytosis screening

Hereditary spherocytosis screening in the news

Blogs on Hereditary spherocytosis screening

Directions to Hospitals Treating Hereditary spherocytosis

Risk calculators and risk factors for Hereditary spherocytosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

The combination of two tests; mean corpuscular hemoglobin concentration (MCHC) and erythrocyte distribution width are an excellent screening tests for hereditary spherocytosis. For young patients with the disease, a full family history, complete blood count (CBC), reticulocyte count and examination of peripheral blood smear on each parent and sibling is required to determine whether the spherocytic mutation is dominant or recessive. For individuals of childbearing age with hereditary spherocytosis, review of familial mutation and its mode of transmission is useful for discussions of likelihood of disease in children.

Screening

References

  1. L. A. Michaels, A. R. Cohen, H. Zhao, R. I. Raphael & C. S. Manno (1997). "Screening for hereditary spherocytosis by use of automated erythrocyte indexes". The Journal of pediatrics. 130 (6): 957–960. PMID 9202619. Unknown parameter |month= ignored (help)
  2. Silvia Eandi Eberle, Gabriela Sciuccati, Mariana Bonduel, Lilian Diaz, Raquel Staciuk & Aurora Feliu Torres (2007). "[Erythrocyte indexes in hereditary spherocytosis]". Medicina. 67 (6 Pt 2): 698–700. PMID 18422060.
  3. Michaels, Lisa A.; Cohen, Alan R.; Zhao, Huaqing; Raphael, Robert I.; Manno, Catherine S. (1997). "Screening for hereditary spherocytosis by use of automated erythrocyte indexes". The Journal of Pediatrics. 130 (6): 957–960. doi:10.1016/S0022-3476(97)70283-X. ISSN 0022-3476.
  4. Christensen RD, Yaish HM, Gallagher PG (2015). "A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates". Pediatrics. 135 (6): 1107–14. doi:10.1542/peds.2014-3516. PMC 4444801. PMID 26009624.

Template:WS Template:WH